JESSICA KINNEY: Open Payments
NPI 1871257865 · YARDLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,199 in 160 payments from 19 companies in 2025. Trend: 2023 $1,973 · 2024 $2,696 · 2025 $3,199
Food & beverage: $3,052Education: $147
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $842 |
| Janssen Biotech, Inc. | 11 | $562 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $231 |
| Madrigal Pharmaceuticals | 13 | $220 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $189 |
| PFIZER INC. | 11 | $183 |
| Ardelyx, Inc. | 15 | $174 |
| Regeneron Healthcare Solutions, Inc. | 6 | $169 |
| Boston Scientific Corporation | 2 | $125 |
| Phathom Pharmaceuticals, Inc. | 8 | $108 |
Products named: TREMFYA, RINVOQ, XIFAXAN, REZDIFFRA, IBSRELA, DUPIXENT, ENTYVIO, General - Hemostasis.
Industry payments across PA — which companies pay providers there.
